© 2004 Fellowship of Postgraduate Medicine
ADVERSE DRUG REACTION
Thrombotic thrombocytopenic purpura associated with statin treatment
Department of Haematology, Leicester Royal Infirmary, Leicester, UK
Correspondence to:
Correspondence to:
Dr S Pavord
Department of Haematology, Leicester Royal Infirmary, Infirmary Square, Leicester LE1 5WW, UK; sp59{at}le.ac.uk
Thrombotic thrombocytopenic purpura (TTP) is a rare condition but associated with 90% mortality if left untreated. The diagnosis is usually made when there is thrombocytopenia and microangiopathic haemolytic anaemia, although the full pentad also includes fever, renal impairment, and neurological dysfunction. A variety of underlying causes have been implicated in acquired TTP including bacterial and viral infections, bone marrow and organ transplantation, pregnancy, immune disorders, and certain drugs. To date there is just one case report of TTP associated with statin treatment. The clinical course of a patient who presented with TTP after being started on simvastatin, a HMG-CoA inhibitor, is described.
Keywords: thrombotic thrombocytopenic purpura; simvastatin; statins
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Pattis, P., Wiedermann, C. J
(2008). Ezetimibe-Associated Immune Thrombocytopenia. The Annals of Pharmacotherapy
42: 430-433
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
